Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KL16-012 in Women With Fibromyalgia
NCT04239469Phase 2Unknown
- Sponsor
- Knop Laboratorios
- Start
- Jan 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of KL16-012 in fibromyalgia (FM), sponsored by Knop Laboratorios. Status: unknown.
02
Drugs
KL16-012
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT04239469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04239469.